| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 上市前/上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 |
| 流动资产： | |||
| 货币资金(元) | 9,138,900.42 | 9,293,002.41 | 18,732,725.29 |
| 应收票据及应收账款(元) | 22,400,006.98 | 19,170,196.53 | 22,034,332.27 |
| 其中：应收账款(元) | 22,400,006.98 | 19,170,196.53 | 22,034,332.27 |
| 预付款项(元) | 4,865,707.95 | 3,911,620.55 | 4,429,529.88 |
| 其他应收款(元) | 764,957.65 | 491,725.95 | 417,382.54 |
| 存货(元) | 8,794,816.61 | 11,307,728.25 | 20,246,811.32 |
| 其他流动资产(元) | 15,955.69 | 239,983.35 | 6,720.06 |
| 流动资产合计(元) | 45,980,345.30 | 44,414,257.04 | 65,867,501.36 |
| 非流动资产： | |||
| 长期股权投资(元) | 19,208,861.68 | 19,208,861.68 | 1,020,000.00 |
| 投资性房地产(元) | 13,627,479.01 | 14,003,105.59 | 14,387,065.03 |
| 固定资产(元) | 7,368,057.18 | 7,067,264.22 | 18,554,724.46 |
| 生产性生物资产(元) | 80,700,859.17 | 82,415,575.73 | 84,016,272.02 |
| 使用权资产(元) | 1,742,993.89 | 1,742,993.89 | 1,794,007.47 |
| 无形资产(元) | - | - | 9,726,513.67 |
| 长期待摊费用(元) | 5,107,604.37 | 5,256,294.15 | 5,431,503.93 |
| 其他非流动资产(元) | 1,031,484.00 | 1,020,000.00 | 1,192,813.54 |
| 非流动资产合计(元) | 128,787,339.30 | 130,714,095.26 | 136,122,900.12 |
| 资产总计(元) | 174,767,684.60 | 175,128,352.30 | 201,990,401.48 |
| 流动负债： | |||
| 短期借款(元) | - | - | 9,697,982.85 |
| 应付票据及应付账款(元) | 918,095.93 | 1,095,903.53 | 1,863,114.01 |
| 其中：应付账款(元) | 918,095.93 | 1,095,903.53 | 1,863,114.01 |
| 合同负债(元) | 4,814,074.63 | 4,995,160.11 | 8,063,356.96 |
| 应付职工薪酬(元) | 2,840,653.17 | 3,214,942.89 | 2,947,353.22 |
| 应交税费(元) | 428,272.80 | 259,171.81 | - |
| 应付利息(元) | 315,036.87 | - | - |
| 其他应付款(元) | 18,398,753.17 | 16,877,200.63 | 21,490,157.04 |
| 一年内到期的非流动负债(元) | 14,126,269.85 | 14,731,274.90 | 11,249,796.58 |
| 其他流动负债(元) | 502,543.64 | 421,678.82 | 502,543.64 |
| 流动负债合计(元) | 42,343,700.06 | 41,595,332.69 | 55,814,304.30 |
| 非流动负债： | |||
| 长期借款(元) | 6,377,725.21 | 5,977,725.21 | 9,477,725.21 |
| 租赁负债(元) | 1,659,498.84 | 1,659,498.84 | 1,808,462.53 |
| 递延收益(元) | 4,546,688.07 | 4,612,164.81 | 2,793,209.55 |
| 非流动负债合计(元) | 12,583,912.12 | 12,249,388.86 | 14,079,397.29 |
| 负债合计(元) | 54,927,612.18 | 53,844,721.55 | 69,893,701.59 |
| 所有者权益(或股东权益)： | |||
| 实收资本或股本(元) | 129,563,106.00 | 129,563,106.00 | 129,563,106.00 |
| 资本公积(元) | 6,904,864.09 | 6,904,864.09 | 6,904,864.09 |
| 盈余公积(元) | 3,451.55 | 3,451.55 | 3,451.55 |
| 未分配利润(元) | -17,884,017.82 | -16,419,615.80 | -5,483,726.03 |
| 归属于母公司股东权益合计(元) | 118,587,403.82 | 120,051,805.84 | 130,987,695.61 |
| 少数股东权益(元) | 1,252,668.60 | 1,231,824.91 | 1,109,004.28 |
| 股东权益合计(元) | 119,840,072.42 | 121,283,630.75 | 132,096,699.89 |
| 负债和股东权益合计(元) | 174,767,684.60 | 175,128,352.30 | 201,990,401.48 |
| 公告日期 | 2023-08-29 | 2023-04-28 | 2022-08-22 |
| 审计意见(境内) | 带强调事项段的无保留意见 | ||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |